Anti-microbial resistance vaccines: communicating their true value
1Center for Vaccine Innovation and Access, PATH, Washington, DC 20001, USA.
Abstract:
Vaccines are incredibly powerful public health tools, but their roles in helping to control anti-microbial resistance (AMR) have been both under- and over-estimated by the public and by the scientific community. Part of the explanation lies in the seeming 'disconnect' between the broad nature of AMR, which affects a wide range of pathogens, and the very focused, pathogen-specific design of most vaccines. With that in mind, the scientific and public health communities can do better in how we communicate the potential value of vaccines against AMR. Even if we do so, however, it is difficult to envision the introduction of new standalone vaccines targeting antimicrobial-resistant pathogens, especially if they require multiple additional doses, into immunization programmes already saturated with a large number of vaccines. To facilitate the introduction of these needed vaccines against AMR into national immunization programmes, the public health community can and should encourage the design and development of combination vaccine formulations. This article is part of the Royal Society Science+ meeting issue 'Vaccines and antimicrobial resistance: from science to policy'.
Insights
Vaccines can help control antimicrobial resistance (AMR), but communication needs improvement. Combination vaccines are key for integrating new AMR vaccines into existing immunization programs.
Area of Science:
- Public Health
- Immunology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a significant global health threat.
- Vaccines are crucial public health tools, yet their role in combating AMR is often misunderstood.
- The specific nature of most vaccines contrasts with the broad impact of AMR.
Purpose of the Study:
- To improve communication regarding vaccines' potential in controlling AMR.
- To explore strategies for integrating new vaccines against AMR into national immunization programs.
- To advocate for combination vaccine formulations to address AMR.
Main Methods:
- Literature review and synthesis of current scientific understanding.
- Analysis of challenges in vaccine introduction into established immunization schedules.
- Policy and scientific community communication strategies.
Main Results:
- The public and scientific communities have underestimated or overestimated vaccines' role in AMR control.
- A perceived disconnect exists between broad AMR and specific vaccine targets.
- Introducing new, single-target AMR vaccines into saturated programs is challenging.
Conclusions:
- Enhanced communication is needed to clarify the value of vaccines against AMR.
- Combination vaccine formulations are essential for successful integration into immunization programs.
- Proactive development of combination vaccines is recommended to combat AMR effectively.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Vaccinations
Antibiotic Selection
Transduction


